Result Summary for C94-071
| Protocol ID: | C94-071 |
| Clinical Study ID: | C94-071 |
| Official Title: | A study to investigate the safety, tolerability and pharmacokinetics of repeat dosing with oral GR85548A for 5 days. |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | naratriptan |
| Trade/Product Name: | amerge;naramig |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
